Latest News & Features
Americas
Celgene and Juno Therapeutics announced yesterday that they have entered into a deal that will see Celgene acquire Juno. 23 January 2018
Big Pharma
The English Court of Appeal has confirmed the revocation of Cubist Pharmaceuticals’ patent relating to antibiotic product daptomycin, on the basis of obviousness. 23 January 2018
Americas
The US Court of Appeals for the Federal Circuit has affirmed a decision by District Judge Rodney Gilstrap in a patent dispute between two medical device companies. 23 January 2018
Asia
Japan-based Abe & Partners has promoted Michiko Kinoshita as partner and Tomohiro Kazama as counsel. 23 January 2018
Americas
Paris-based Sanofi has revealed plans to acquire Bioverativ, a US-based biotech company focused on haemophilia treatments. 23 January 2018
Asia
Germany-based Sandoz has entered into a partnership with Biocon to develop, manufacture and commercialise biosimilars in immunology and oncology. 22 January 2018
Americas
Generics company Mylan Pharmaceuticals has resisted Allergan’s attempt to withdraw itself from a series of inter partes reviews (IPRs) relating to patents covering dry-eye medication Restasis (cyclosporine ophthalmic emulsion). 19 January 2018
Europe
Commentators have offered differing opinions on the impact of yesterday’s decision by the European Patent Office to revoke a CRISPR/Cas9 patent owned by the Broad Institute of Harvard and MIT. 18 January 2018
Americas
The Patent Trial and Appeal Board has invalidated a Johnson & Johnson patent covering its prostate cancer drug Zytiga (abiraterone acetate). 18 January 2018
Big Pharma
The UK Supreme Court has granted the UK BioIndustry Association permission to intervene in the case of Warner-Lambert Company v Generics and Actavis, which concerns the issue of ‘plausibility’. 18 January 2018